GIBU
ALNY icon

Gulf International Bank (UK)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Gulf International Bank (UK)’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.37M Buy
10,197
+3,570
+54% +$1.21M 0.08% 245
2025
Q4 		$2.63M Buy
6,627
+249
+4% +$110K 0.09% 214
2025
Q3 		$2.91M Sell
6,378
-117
-2% -$47.6K 0.1% 201
2025
Q2 		$2.12M Sell
6,495
-869
-12% -$240K 0.07% 255
2025
Q1 		$1.99M Sell
7,364
-2,390
-25% -$614K 0.07% 274
2024
Q4 		$2.29M Sell
9,754
-99
-1% -$26K 0.06% 296
2024
Q3 		$2.71M Sell
9,853
-475
-5% -$124K 0.07% 269
2024
Q2 		$2.51M Hold
10,328
– – 0.06% 280
2024
Q1 		$1.54M Hold
10,328
– – 0.04% 389
2023
Q4 		$1.98M Sell
10,328
-968
-9% -$165K 0.06% 317
2023
Q3 		$2M Sell
11,296
-1,274
-10% -$243K 0.06% 321
2023
Q2 		$2.39M Sell
12,570
-3,691
-23% -$732K 0.06% 318
2023
Q1 		$3.26M Sell
16,261
-3,725
-19% -$783K 0.07% 297
2022
Q4 		$4.75M Buy
19,986
+75
+0.4% +$16K 0.08% 264
2022
Q3 		$3.98M Sell
19,911
-195
-1% -$37.2K 0.08% 271
2022
Q2 		$2.93M Buy
20,106
+195
+1% +$27.7K 0.05% 354
2022
Q1 		$3.25M Hold
19,911
– – 0.05% 381
2021
Q4 		$3.38M Sell
19,911
-3,700
-16% -$688K 0.05% 381
2021
Q3 		$4.46M Hold
23,611
– – 0.06% 345
2021
Q2 		$4M Sell
23,611
-150
-0.6% -$22K 0.05% 386
2021
Q1 		$3.35M Sell
23,761
-2,600
-10% -$391K 0.05% 403
2020
Q4 		$3.43M Sell
26,361
-2,920
-10% -$390K 0.04% 410
2020
Q3 		$4.26M Hold
29,281
– – 0.06% 303
2020
Q2 		$4.34M Hold
29,281
– – 0.07% 289
2020
Q1 		$3.19M Hold
29,281
– – 0.06% 302
2019
Q4 		$3.37M Hold
29,281
– – 0.05% 362
2019
Q3 		$2.35M Buy
29,281
+9,300
+47% +$736K 0.04% 450
2019
Q2 		$1.45M Hold
19,981
– – 0.02% 557
2019
Q1 		$1.87M Buy
19,981
+734
+4% +$61.4K 0.03% 499
2018
Q4 		$1.4M Sell
19,247
-9,900
-34% -$761K 0.03% 516
2018
Q3 		$2.55M Hold
29,147
– – 0.03% 505
2018
Q2 		$2.87M Hold
29,147
– – 0.04% 513
2018
Q1 		$3.47M Sell
29,147
-703
-2% -$90.6K 0.05% 440
2017
Q4 		$3.79M Buy
+29,850
New +$3.75M 0.05% 414
2016
Q4 		– Sell
-25,100
Closed -$1.7M – 715
2016
Q3 		$1.7M Buy
25,100
+2,000
+9% +$141K 0.03% 598
2016
Q2 		$1.28M Hold
23,100
– – 0.02% 642
2016
Q1 		$1.45M Hold
23,100
– – 0.02% 624
2015
Q4 		$2.17M Buy
23,100
+220
+1% +$20.4K 0.04% 515
2015
Q3 		$1.84M Hold
22,880
– – 0.03% 555
2015
Q2 		$2.74M Buy
+22,880
New +$2.73M 0.05% 427

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gulf International Bank (UK)'s ALNY Position: Q1 2026 in Review

Gulf International Bank (UK) increased its Alnylam Pharmaceuticals (ALNY) stake by 54% in Q1 2026, buying an estimated $1.21M and bringing the position to 10,197 shares worth $3.37M. The position accounts for 0.08% of the portfolio, ranked #245.

Gulf International Bank (UK) first reported a position in ALNY in Q2 2015 and has held it in 40 quarters since. The position peaked at $4.75M in Q4 2022. 787 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Gulf International Bank (UK) held 10,197 shares of Alnylam Pharmaceuticals worth $3.37M as of Q1 2026.
  • Gulf International Bank (UK) bought 3,570 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $1.21M.
  • Alnylam Pharmaceuticals made up 0.08% of Gulf International Bank (UK)'s portfolio in Q1 2026, its #245 holding.
  • Gulf International Bank (UK) first reported a position in Alnylam Pharmaceuticals in Q2 2015 and has held it in 40 quarters since.
  • Gulf International Bank (UK)'s Alnylam Pharmaceuticals position peaked at $4.75M in Q4 2022.
  • 787 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Gulf International Bank (UK)'s 13F filing for Q1 2026, filed 11 May 2026.